Arsenic exposure and its health effects and risk of cancer in developing countries: Micronutrients as host defence

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 1, 2007, Pages 13-23

  Anetor, John I ^a,b   Wanibuchi, Hideki ^a   Fukushima, Shoji ^a,c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c Japan Bioassay Research Center   (Japan)

Author keywords

Arsenic; Carcinogenicity; Contamination; Health; Malignancies; Micronutrients; Nutrition

Indexed keywords

TRACE ELEMENT;

ARSENIC POISONING; DIET THERAPY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMAN; NEOPLASM; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT;

ARSENIC POISONING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; MICRONUTRIENTS; NEOPLASMS; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 34547737043     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Albores A, Cebrian ME, Bach PH, et al. (1995). Sodium arsenite induced alteration in bilirubin excretion and heme metabolism. J Biochem Toxicol, 69, 498-504
2. Anetor JI, Yaqub SA, Akingbola TS, et al. (2005). Mixed chemical toxicity associated oxidative stress in occupational exposure: significance for genome stability. Nigerian Association of Clinical Chemists, Bi-Annual Scientific Conference, University of Calabar, Nigeria, Book of Abstracts, pp 19-20
3. Basu A, Mahara J, Gupta S, et al. (2001). Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res, 488, 171-194
4. Bates MN, Smith AH, Cantor KP (1995). Case control study of bladder cancer and arsenic in drinking water. Am J Epidemiol, 142, 523-30
5. Bates MN, Smith AH, Hopenhayn-Rich C (1992). Arsenic ingestion and internal cancers: a review. Am J Epidemiol, 36, 462-76
6. Baunnann PF, Smith TK, Bray TM (1988). The effect of dietary proteins and sulfur amino acids on hepatic glutathione concentration and glutathione dependent enzyme activities in the rat. Can J Physiol Pharmacol, 63, 1048-52
7. Beck BD, Boardman PD, Hook GC, et al. (1995). Response to Smith et al. (Letter). Environ Health Perspect, 103, 15-7
8. Berstam L, Nriagu J (2000). Molecular aspects of arsenic stress. J Tox Environ Health B, 3, 293-322
9. Bertolero F, Maranfate E, Rande JE, et al. (1981). Biotransformation and intracellular binding of arsenic in tissue of rabbits after intracellular administration of 74 As labeled arsenite. Toxicology, 20, 35-44
10. Blot WJ, Fraumeni JF Jr (1975). Arsenical air pollution and lung cancer. Lancet, 2, 142-4
11. Bogono JM, Greiber R (1971). Estudio epidemiologico el arsenicismo en la ciudad de Anto fagasta. Rev Med Chile, 99, 702
12. Bogono JM, Vincent P, Venturiano H, et al. (1977). Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of the treatment plant. Environ Health Perspect, 19, 103-5
13. Bondy SC (1996). Oxygen generation as a basis for neurotoxicity by metals. In: Toxicology of Metals. Chang LW, Eds CRC Press Boca, Raton, pp 699-706
14. Bray TM, Taylor CG (1993). Tissue glutathione, nutrition and oxidative stress. Can J Physiol Pharmacol, 71, 746-51
15. Buchet JP, Lauwerys R, Roels N (1980). Comparison of several methods for the determination of arsenic compounds in waterand urine. Their application for the study of arsenic metabolism and for monitoring of workers exposed to arsenic. Int Arch Occup Environ Health, 46, 11-29
16. Carson R (2002). Elixirs of Death. In Silent Spring. A Mariner Book, Houghton Mifflin Company, Boston, pp 17-18, 219-23
17. Cerbian ME, Albores A, Aguilar M, et al. (1983). Chronic arsenic poisoning in North Mexico. Human Toxicol, 2, 121-33
18. Chen CJ, Hsueh YM, Laiu MS, et al. (1995). Increased prevalence of hypertension and long-term arsenic exposure. Hypertension, 25, 53-60
19. Chen JC, Wang CJ (1990). Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasma, Cancer Res, 50, 5470-4
20. Chen T, Na Y, Wanibuchi H, et al. (1999). Difference of promoting activating and loss of heterozygosity between dimethylarsinic acid and sodium L-ascorbate in F1 rat urinary bladder carcinogenesis. Arsenic Exposure and Health Effects. Chappell WR, Abernathy CO, Calderon RL(eds), Elsevier Science, pp 263-6
21. Cheu NY, Cheu ST, HSU, et al. (2001). Incidence of transitional cell carcinoma and arsenic in drinking water: a follow up in 102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol, 153, 411-8
22. Chow CK (1979). Nutritional influences on cellular antioxidant defense systems. Am J Clin Nutr, 32, 1066-8
23. Chow CK (1991). Vitamin E and oxidative stress. Free Rad Biol Med, 11, 215-52
24. Chow CK (2002). Antioxidant nutrients and environmental health: Introduction. Toxicology, 180, 1-3
25. Clayson DB (2001). Toxicological Carcinogenesis. Lewis Publishers, Boca Raton, pp 26, 158
26. Cohen SM, Arnold LL, Eldan M, et al. (2006). Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk. Crit Rev Toxicol, 36(2), 99-133
27. Cullen WR, McBride BC, Reghinski J (1984). The reaction of methylarsenicals with thiols: some biological implications. J Inorg Biochem, 21, 179-93
28. Engel RR, Hopenhayn RC, Receiveur O, et al. (1994). Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev, 16, 184-209
29. Engel RR, Receiveur O (1993). Arsenic ingestion and internal cancers: a review (Letter). Am J Epidemiol, 138, 896-7
30. Ercal N, Guerer-Orhan H, Aykin-Burns N (2001). Toxic metals and oxidative stress, part I: Mechanisms involved in metal induced oxidative damage. Curr Top Med Chem, 1, 529-9
31. Ferm VH (1977). Arsenic as a teratogenic agent. Environ Health Perspect, 19, 215-7
32. Forman MR, Yao SX, Graubard BI, et al. (1992). The effect of dietary intake of fruits and vegetables on the odd ratio of lung cancer among Yunan tin miners. Int J Epidemiol, 21, 437-41
33. Fukushima S, Takada N, Wanibuchi H, et al. (2001). Suppression of chemical carcinogenesis by water soluble organosulfur compounds. In: Recent Advances on the Nutritional Effects Associated with the Use of Garlic as a Supplement. J Nutr, 131, 1049s-53s
34. Gebel TW (2000). Genotoxicity of arsenical compounds. Int. J Hyg Environ Health, 203, 249-62
35. Gebel TW (2001). Unanswered questions in arsenic toxicology. J Environ Pathol Toxicol Oncol, 20, 299-309
36. Gibson R (1994). Zinc nutrition in developing countries. Nutr Res Rev, 7, 1-73
37. Goerring Pl, Aposhian HV, Mass J, et al. (1999). The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci, 49, 5-14
38. Gonzatez MJ, Aguilar MV, Martinez-para MC (1995). Gastroinstinal absorption of inorganic arsenic(v): the effect of concentration and interactions with phosphate and dichromate. Vet Hum Toxicol, 37, 131-6
39. Gresser MJ (1981).ADP-arsenate formation by submitochondrial particles under phosphorylating conditions. J Biol Chem, 256, 5981-3
40. Harrington JM, Middaugh JP, Morse DL, et al. (1978). A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska. Am J Epidemiol, 108, 377-85
41. Hill CH (1975). Interrelationship of selenium with other trace elements. FASEB J, 34, 2096-100
42. Huerper WC (1957). Newer developments in occupational and environmental cancer. AMA Arch Int Med, 100, 487-503
43. Hultberg B, Andersson A, Isaksson A (2001). Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. Toxicology, 156, 93-100
44. Hutchinson (1895). On some examples of arsenic keratosis of the skin and of arsenic cancer. Trans path Soc Lond, 39, 352-93
45. IARC (International Agency for Research on Cancer) (1987). Monograph on the Evaluation of Carcinogenic Risk to Humans: Over all evaluation - carcinogenicity: an updating of IARC monographs, 1-42 (suppl 7)
46. Islam FS, Gault AG, Boothman C, et al. (2004). Role of metalreducing bacteria in arsenic release from Bengal delta sediments. Nature, 430, 68-71
47. Kitchin KT (2001). Recent advances in arsenic carcinogenesis: Modes of action of animal model systems and methylated arsenic metabolites. Toxicol Appl Pharmacol, 172, 249-61
48. Kreppel H, Liu J, Liu Y, et al. (1994). Zinc-induced arsenite tolerance in mice. Fundam Appl Toxicol, 23, 32-7
49. Lai MS, Hsueh YM, Chen CJ, et al. (1994). Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol, 139, 484-92
50. Lee TC, Ho IC (1994). Differential cytotoxic effects of arsenic in human and animal cells. Environ Health perspect, 102(suppl 3), 1001-105
51. Lee TC, Ho IC (1995). Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch J Toxicol, 69, 498-504
52. Levander OA (1977). Metabolism interrelationships between arsenic and selenium. Environ Health Perspect, 19, 159-64
53. Levander OA, Baumann CA (1966). Selenium metabolism. VI: Effect of arsenic on the excretion of selenium in the bile. Toxicol Appl Pharmacol, 9, 106-15
54. Levin HM, Poll EE, Galloway R, et al. (1993). Micronutrient deficiency disorders. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL eds. Disease control priorities in developing countries. Oxford Medical Publications (Published for the World Bank) Oxford, pp 21-451
55. Li W, Wanibuchi H, Salim El, et al. (1998). Promotion of NCIBlack-Reiter male rat bladder carcinogenesis by dimethylarsinic acid, an organic arsenic compound. Cancer Lett, 134, 29-36
56. Meister A (1994). Glutathione, ascorbate and cellular protection. Cancer Res, 54 (suppl), 1969s-75s
57. Mitchell RA, Chang BF, Huang CH, et al. (1971). Inhibiton of mitochondrial energy-linked functions by arsenate: evidence for a non-hydrolytic mode of inhibitor action. Biochemistry, 10, 2049-54
58. Modi M, Gupta R, Prasad GBKS, et al. (2004). Protective value of concomitant administration of trace elements against arsenic toxicity in rats. J Tissue Res, 4, 257-62
59. Mushak P, Crocetti AF (1995). Risk and revisionism in arseniccancer risk assessment in arsenic cancer risk assessment. Environ Health Perspect, 103, 684-9
60. Nishikawa T, Wanibuchi H, Ogawa M, et al. (2001). Promoting effects of monomethylarsonic acid, dimethylarsinic acid, and trimethylarsine oxide on rat liver preneoplastic glutathione S-transferase placental form positive foci: a possible reactive oxygen species mechanism. Int J Cancer, 100, 136-9
61. NRC (National Research Council) (1999). Arsenic in the Drinking Water. National Academy Press, Washington, Dc, pp 1-310
62. Parkin DM, Pisani P, Ferlay J (1993). Estimates of the world wide incidence of eighteen major cancers. Int J Cancer, 54, 594-606
63. Phillip PR (1985). Arsenic exposure: Health effects and the risk of cancer. Rev Environ Health, 5, 27-57
64. Pott P (1775). Chururigical observation relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures and the modification of the Toes and Feet; James Clarke and Gillie, London
65. Quig D (1998). Cysteine metabolism and metal toxicity. Alt Med Rev, 3, 262-70
66. Rahman M, Axelson O (1995). Diabetes mellitus and arsenic exposure: a second look at case-control data from Swedish copper smelter. Occup Environ Med, 52, 773-4
67. Ramos O, Carrizalens L, Yanez L, et al. (1995). Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environ Health Perspect, 103(suppl), 85-8
68. Roychoudhury A, Dast Sharma A, Talukdar G, (1996). Dietary garlic extraction modifying clastogenic effects of inorganic arsenic in mice: two generation studies. Mutat Res, 359, 165-70
69. Sakoda LC, Graubard BI, Evans AE, et al. (2005). Toe nail selenium and risk of hepatocellular carcinoma mortality in Haimen City. China Int J Cancer, 115, 618-24
70. Schrauzer GN, White D, McGinness JE, et al. (1978). Arsenic and cancer: effects of joint administration of arsenite and selenite on the genesis of mammary adenocarcinoma in inbred female C3H/S+ mice. Bioinorg Chem, 9, 245-53
71. Schwartz RA, (1997). Arsenic and the skin. Int J Dermatol, 36, 241-50
72. Shi N, Shi Y, Liu J (2004). Oxidative mechanisms of arsenic toxicity and carcinogenesis. Mol Cell Biochem, 255, 67-8
73. Shivapurkar N, Poirier LA (1983). Tissue levels of S-adenosine methionine and S-adenosine homocysteine in rats fed methyl-deficient amino acid defined diets for one to five weeks. Carcinogenesis, 4, 1051-7
74. Smith AH, Goycola M, Haque R, et al. (1998). Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am J Epidemiol, 147, 660-9
75. Southorick JW, Western AE, Beck MM, et al. (1983). An epidemiological study of arsenic in drinking water in Millard County, Utah. In; Arsenic Industrial Biomedical and Environmental Health perspectives, Lederer W, Fensterheim W (eds.) New York, Van Nostrand-Reinhold, pp 210-25
76. Steinmaus C, Moore L, Hopehayn-Rich C, et al. (2000). Arsenic in drinking water and bladder cancer. Cancer Invest, 18, 174-82
77. Steinmetz KA, Potter JD (1991). Vegetables, fruit and cancer, I. Epidemiology. Cancer Cause Control, 2, 325-57
78. Sultana S, Ahmed S, Jahangiv T, et al. (2005). Inhibitory effect of celery seeds extract on chemically induced hepatocarcinogenesis: modulation of cell proliferation, metabolism and altered hepatic foci development. Cancer Lett
79. Szsinicz L (1988). Forth W. Effects of As2O3 on gluconeogenesis. Arch Toxicol, 61, 444-9
80. Tam GK, Charbonneau SM, Bryce F, et al. (1997). Metabolism of inorganic arsenic (74As) in human following oral ingestion. Toxicol Appl Pharmacol, 50, 319-22
81. Tseng CH, Chong CK, Chen CJ, et al. (1996). Dose-response relation between peripheral vascular disease and ingested inorganic arsenic among residents in black foot disease villages in Taiwan. Atherosclerosis, 120, 125-33
82. Tseng CH, Chong CK, Heng LT, et al. (2000). The incidence of type II diabetes mellitus in Taiwan. Diabetes Res Clin Pract, 5 (suppl), s61-s64
83. Tseng WP, Chu HM, How WW, et al. (1968). Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst, 40, 453-63
84. Underwood B, Smitasiri S (1999). Micronutrient malnutrition: Policies and programs for control and their implications. Ann Rev Nutr, 19, 303-24
85. Vahter M (1981). Biotransformation of trivalent inorganic arsenic in mice and rats. Environ Res, 25, 286-96
86. Vahter M, Concha G, (2001). Role of metabolism in arsenic toxicity. Pharmacol Toxicol, 89, 211-7
87. Vahter M, Maranfante E, (1987). Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett, 37, 41-6
88. Valentine JL, Cebrian ME, Garcia-Vargas GG, et al. (1994). Daily selenium intake estimates for residents of arsenic endemic area. Environ Res, 64, 1-9
89. Valentine JL, He S-Y, Resbord LS, et al. (1992). Health response by questionnaire in arsenic exposed populations. J Clin Epidemiol, 45, 487-494
90. Valenzuela OL, Borja-Aburto VH, Garcia-vargas GG, et al. (2005). Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Cancer Res, 65, 250-4
91. Wagner SL, Maliner JS, Morton WE, et al. (1979). Skin cancer and arsenical intoxication from well water. Arch Dermatol, 115, 1205-7
92. Wang CT, Chang WT, Hyang CW, et al. (1994). Studies on the concentration of arsenic, selenium, copper, zinc and iron in the hair of Blackfoot disease patients in different clinical stages. Eur J Clin Chem Clin Biochem, 32, 107-11
93. Wanibuchi H, Hori T, Meenahshi V, et al. (1997). Promotion of rat hepatocarcinogenesis by dimethylarsinic acid as assessed in rat in vivo models: a review. Mutat Res, 386, 353-61
94. Wanibuchi H, Hori T, Meenaksin V, et al. (1997). Promotion of rat hepatocarcinogenesis by dimethylarsinic acid: association of elevated ornithine decarboxylase activity and formation of 8-hydroxyguanosine in the liver. Jpn J Cancer Res, 88, 1149-54
95. Wanibuchi H, Salim EI, Kinoshita A, et al. (2004). Understanding arsenic carcinogenicity by the use of animal models. Toxicol Appl Pharmacol, 198, 366-78
96. Wanibuchi H, Yamamoto S, Chen H, et al. (1996). Promotion effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl) nitrosamine - induced urinary bladder carcinogenesis in rats. Carcinogenesis, 17, 2435-9
97. Wattenberg LW (1990). Inhibition of carcinogenesis by naturally occurring and synthetic compounds. In: Kuroda Y, Shankel DM, Waters MD eds. Antimutagenesis and Anticarcinogenesis, Mechanisms II, Plenum Publishing Corp, New York, pp 155-66
98. Wei M, Arnord L, Cano M, et al. (2005). Effects of coadministration of antioxidants and arsenicals on rat urinary bladder epithelium. Toxicol Sci, 83, 237-45
99. Wei M, Wanibuchi H, Morimura K, et al. (2002). Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations induced in urinary bladder tumors.Carcinogenesis, 32, 1387-7
100. Wei M, Wanibuchi H, Yamamoto S, et al. (1999). Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis, 20, 1873-6
101. Winski SL, Carter DE (1995). Interactions of rat red blood cell sulphydryl with arsenate and arsenite. J Toxicol Environ Health, 46, 379-97
102. Yamamoto S, Konishi Y, Matsuda T, et al. (1995). Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid) in F344 Ducrj rats after pretreatment with five carcinogens. Cancer Res, 55, 1271-6
103. Yamanaka K, Haegawa A, Sawamura R, et al. (1989). Dimethyl arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Arsenic ingestion and internal cancers: a review. Biochem Biophys Res Comm, 1965, 43-50
104. Yamanaka K, Mizoi M, Kato K, et al. (2001). Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic in mice promotes skin tumourigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter in mice. Biol Pharm Bull, 24, 510-4
105. Zaldivar R, Viullav I, Wetterstrand WH, et al (1978). Epidemiological dietary toxicological and clinical nutrition studies on low-income population groups from a geographical area with endemic chronic arsenic poisoning. Zentralbl Bakteriol 13, 167, 242-7